PMID- 29660438 OWN - NLM STAT- MEDLINE DCOM- 20190108 LR - 20220115 IS - 1096-0333 (Electronic) IS - 0041-008X (Linking) VI - 352 DP - 2018 Aug 1 TI - Prenatal nicotine exposure intergenerationally programs imperfect articular cartilage via histone deacetylation through maternal lineage. PG - 107-118 LID - S0041-008X(18)30104-2 [pii] LID - 10.1016/j.taap.2018.03.018 [doi] AB - Accumulating evidence has shown that the impact of prenatal environmental factors on the organs of the offspring could last until the adulthood. Here, we aimed to investigate these effects and the potential mechanism of prenatal nicotine exposure (PNE) on the female adult cartilage of the first generation (PNE-F1) and the second generation (PNE-F2). Pregnant Wistar rats were injected with 2.0 mg/kg.d nicotine from gestational day (GD) 9 to 20. Then their F1 generation at GD20 and postnatal week (PW) 12, and F2 generation at PW12 were harvested. The expression of extracellular matrix (ECM) and transforming growth factor beta (TGFbeta) signaling genes were analyzed by real-time quantitative PCR, and the histone acetylation was examined by chromatin immunoprecipitation assay. The results showed that PNE reduced the ECM and TGFbeta signaling gene expressions in both PNE-F1 and PNE-F2 female adult articular cartilage. In the F1 generation, PNE inhibited the acetylation at H3K9 of TGFbeta, TGFbeta receptor 1 (TGFbetaR1), SRY-type high mobility group box 9 (SOX9), a1 chain of type II collagen (COL2A1) and aggrecan (ACAN) gene promoters at both GD20 and PW12. In PNE-F2 at PW12, the obvious deacetylation at H3K9 of the TGFbetaR1 and COL2A1 promoters still existed. Moreover, in rat fetal chondrocytes, corticosterone rather than nicotine directly induced the hypoacetylation of H3K9 of TGFbetaR1 and COL2A1 genes, which might be the main cause of imperfect cartilage for PNE-F2. This study may be helpful to elucidate the developmental variability of articular cartilage quality and useful for the early prevention of articular damage. CI - Copyright (c) 2018. Published by Elsevier Inc. FAU - Xie, Zhe AU - Xie Z AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. FAU - Zhao, Zhe AU - Zhao Z AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. FAU - Yang, Xu AU - Yang X AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. FAU - Pei, Linguo AU - Pei L AD - Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China. FAU - Luo, Hanwen AU - Luo H AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. FAU - Ni, Qubo AU - Ni Q AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. FAU - Li, Bin AU - Li B AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China. FAU - Qi, Yongjian AU - Qi Y AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. FAU - Tie, Kai AU - Tie K AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. FAU - Magdalou, Jacques AU - Magdalou J AD - UMR 7561CNRS, Universite de Lorraine, Faculte de Medicine, Vandoeuvre-les-Nancy, France. FAU - Chen, Liaobin AU - Chen L AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. Electronic address: lbchen@whu.edu.cn. FAU - Wang, Hui AU - Wang H AD - Department of Orthopedic Surgery, Zhongnan Hospital of Wuhan University, Wuhan 430071, China; Department of Pharmacology, Basic Medical School of Wuhan University, Wuhan 430071, China; Hubei Provincial Key Laboratory of Developmentally Originated Diseases, 185 Donghu Road, Wuchang District, Wuhan 430071, China. Electronic address: wanghui19@whu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180413 PL - United States TA - Toxicol Appl Pharmacol JT - Toxicology and applied pharmacology JID - 0416575 RN - 0 (Aggrecans) RN - 0 (COL2A1 protein, rat) RN - 0 (Collagen Type II) RN - 0 (Histones) RN - 0 (Nicotinic Agonists) RN - 6M3C89ZY6R (Nicotine) RN - EC 2.7.11.30 (Receptor, Transforming Growth Factor-beta Type I) RN - EC 2.7.11.30 (Tgfbr1 protein, rat) SB - IM EIN - Toxicol Appl Pharmacol. 2022 Feb 15;437:115865. PMID: 35032483 MH - Acetylation MH - Age Factors MH - Aggrecans/genetics/metabolism MH - Animals MH - Cartilage, Articular/*drug effects/metabolism/pathology MH - Cells, Cultured MH - Chondrocytes/drug effects/metabolism/pathology MH - Chondrogenesis/*drug effects/genetics MH - Collagen Type II/genetics/metabolism MH - Female MH - Gene Expression Regulation, Developmental/drug effects MH - Gestational Age MH - Histones/*metabolism MH - Male MH - Nicotine/administration & dosage/*toxicity MH - Nicotinic Agonists/administration & dosage/*toxicity MH - Pregnancy MH - *Prenatal Exposure Delayed Effects MH - Rats, Wistar MH - Receptor, Transforming Growth Factor-beta Type I/genetics/metabolism MH - Signal Transduction/drug effects OTO - NOTNLM OT - Articular cartilage OT - Histone deacetylation modification OT - Intergenerational transmission OT - Nicotine prenatal exposure OT - Transforming growth factor beta EDAT- 2018/04/17 06:00 MHDA- 2019/01/09 06:00 CRDT- 2018/04/17 06:00 PHST- 2017/11/11 00:00 [received] PHST- 2018/02/15 00:00 [revised] PHST- 2018/03/14 00:00 [accepted] PHST- 2018/04/17 06:00 [pubmed] PHST- 2019/01/09 06:00 [medline] PHST- 2018/04/17 06:00 [entrez] AID - S0041-008X(18)30104-2 [pii] AID - 10.1016/j.taap.2018.03.018 [doi] PST - ppublish SO - Toxicol Appl Pharmacol. 2018 Aug 1;352:107-118. doi: 10.1016/j.taap.2018.03.018. Epub 2018 Apr 13.